The bispecific anti-CD3 × anti-CD155 antibody mediates T cell immunotherapy for human prostate cancer
{{output}}
Expression of CD155 differs between tumor and normal tissues, and high expression of this molecule can promote tumor metastasis. Here, we investigate whether CD155 can serve as a target for T cell-mediated immunotherapy of human prostate cancer. We first demon... ...
